TWO SIGMA INVESTMENTS, LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,882,046
-63.1%
628,320
-54.1%
0.01%
-60.6%
Q2 2023$13,243,895
+67.0%
1,368,171
+89.1%
0.03%
+43.5%
Q1 2023$7,930,678
+193.6%
723,602
+15.7%
0.02%
+187.5%
Q4 2022$2,700,747
-31.5%
625,173
+19.3%
0.01%
-38.5%
Q3 2022$3,942,000
+2348.4%
524,246
+4710.0%
0.01%
+1200.0%
Q3 2020$161,000
-54.9%
10,899
-55.7%
0.00%
-66.7%
Q1 2020$357,000
-91.1%
24,599
-95.5%
0.00%
-78.6%
Q1 2017$4,028,000548,7710.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders